These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8357510)

  • 1. Second malignancies after chemotherapy and transplantation.
    Gertz MA; Noël P; Kyle RA
    Crit Rev Oncol Hematol; 1993 Apr; 14(2):107-25. PubMed ID: 8357510
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-Transplantation Lymphoproliferative Disorders in Adults.
    Dierickx D; Habermann TM
    N Engl J Med; 2018 Feb; 378(6):549-562. PubMed ID: 29414277
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular genetic analysis of post-transplant lymphoproliferative disorders.
    Seiden MV; Sklar J
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):447-65. PubMed ID: 8385661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules.
    Kampers J; Orjuela-Grimm M; Schober T; Schulz TF; Stiefel M; Klein C; Körholz D; Mauz-Körholz C; Kreipe H; Beier R; Maecker-Kolhoff B
    Leuk Lymphoma; 2017 Mar; 58(3):633-638. PubMed ID: 27685149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.
    Fassas AB; Tricot G
    Cancer Treat Res; 2001; 108():169-84. PubMed ID: 11702599
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapy-related myeloid neoplasms.
    Larson RA
    Haematologica; 2009 Apr; 94(4):454-9. PubMed ID: 19336749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplant immunosuppression-related malignant lymphomas.
    Swinnen LJ
    Cancer Treat Res; 1993; 66():95-110. PubMed ID: 8102866
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus and posttransplant lymphoproliferative disease.
    Holmes R
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):442-4. PubMed ID: 11698760
    [No Abstract]   [Full Text] [Related]  

  • 9. Posttransplant lymphoproliferative diseases.
    Gross TG; Savoldo B; Punnett A
    Pediatr Clin North Am; 2010 Apr; 57(2):481-503, table of contents. PubMed ID: 20371048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgical implications of the posttransplant lymphoproliferative disorders.
    Stieber AO; Boillot O; Scotti-Foglieni C; Nalesnik MA; Gordon RD; Marino I; Mazzaferro V; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1477-9. PubMed ID: 1989270
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.
    Nalesnik MA; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1108-10. PubMed ID: 1703335
    [No Abstract]   [Full Text] [Related]  

  • 12. EBV-induced post-transplant lymphoproliferative disorder (PTLD).
    Birkeland SA; Hamilton-Dutoit S; Sandvej K; Andersen HM; Bendtzen K; Møller B; Jørgensen KA
    Transplant Proc; 1995 Dec; 27(6):3467-72. PubMed ID: 8540055
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphoproliferative disease in organ transplant recipients.
    Nalesnik MA
    Springer Semin Immunopathol; 1991; 13(2):199-216. PubMed ID: 1664986
    [No Abstract]   [Full Text] [Related]  

  • 14. The Seville expert workshop for progress in posttransplant lymphoproliferative disorders.
    Glotz D; Chapman JR; Dharnidharka VR; Hanto DW; Castro MC; Hirsch HH; Leblond V; Mehta AK; Moulin B; Pagliuca A; Pascual J; Rickinson AB; Russo FP; Trappe RU; Webster AC; Zuckermann AO; Gross TG
    Transplantation; 2012 Oct; 94(8):784-93. PubMed ID: 22992767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of EBV in post-transplant malignancies: a review.
    Hopwood P; Crawford DH
    J Clin Pathol; 2000 Apr; 53(4):248-54. PubMed ID: 10823119
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent increased Epstein-Barr virus loads after solid organ transplantation: truth and consequences?
    Green M; Webber SA
    Liver Transpl; 2007 Mar; 13(3):321-2. PubMed ID: 17318870
    [No Abstract]   [Full Text] [Related]  

  • 17. A new form of T-cell PTLD.
    Litz C; Hanson M
    Am J Clin Pathol; 2000 Apr; 113(4):598. PubMed ID: 10761467
    [No Abstract]   [Full Text] [Related]  

  • 18. Posttransplantation lymphoproliferative disorders (PTLD): current perspectives.
    Nalesnik MA
    Semin Thorac Cardiovasc Surg; 1996 Apr; 8(2):139-48. PubMed ID: 8672567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
    Zimmermann H; Oschlies I; Fink S; Pott C; Neumayer HH; Lehmkuhl H; Hauser IA; Dreyling M; Kneba M; Gärtner B; Anagnostopoulos I; Riess H; Klapper W; Trappe RU
    Transplantation; 2012 Mar; 93(5):543-50. PubMed ID: 22234349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplantation lymphoproliferative disorder and OKT3.
    N Engl J Med; 1991 May; 324(20):1437-9. PubMed ID: 2020303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.